Chapter 3. Pharmacology of Parkinson's Disease

  1. Mark Hallett2 and
  2. Werner Poewe3
  1. Jonathan M. Brotchie

Published Online: 29 OCT 2008

DOI: 10.1002/9780470713990.ch3

Therapeutics of Parkinson's Disease and Other Movement Disorders

Therapeutics of Parkinson's Disease and Other Movement Disorders

How to Cite

Brotchie, J. M. (2008) Pharmacology of Parkinson's Disease, in Therapeutics of Parkinson's Disease and Other Movement Disorders (eds M. Hallett and W. Poewe), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470713990.ch3

Editor Information

  1. 2

    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA

  2. 3

    Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria

Author Information

  1. Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON, Canada

Publication History

  1. Published Online: 29 OCT 2008
  2. Published Print: 17 OCT 2008

ISBN Information

Print ISBN: 9780470066485

Online ISBN: 9780470713990

SEARCH

Keywords:

  • Parkinson's disease;
  • PD;
  • parkinsonism;
  • pharmacology;
  • basal ganglia;
  • therapeutics

Summary

This chapter contains sections titled:

  • Overview

  • A Circuit-Based Model of Basal Ganglia Pharmacology

  • Cellular and Molecular Pharmacology of the Basal Ganglia

  • Pharmacology of Therapeutics in Parkinson's Disease: Current Status and Emerging Opportunities

  • Conclusions

  • References